Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. The Piperacillin/Tazobactam Skin and Skin Structure Study Group.

Podobne zapisy

• Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.
  od: Fass, R J, i wsp.
  Wydane: (1989)
• Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid.
  od: Van der Auwera, P, i wsp.
  Wydane: (1993)
• Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone.
  od: Pankuch, G A, i wsp.
  Wydane: (1994)
• Comparison of the bactericidal activities of piperacillin-tazobactam, ticarcillin-clavulanate, and ampicillin-sulbactam against clinical isolates of Bacteroides fragilis, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa.
  od: Klepser, M E, i wsp.
  Wydane: (1997)
• Ertapenem Once a Day Versus Piperacillin–Tazobactam Every 6 Hours for Treatment of Acute Pelvic Infections: A Prospective, Multicenter, Randomized, Double-Blind Study
  od: Subir Roy, i wsp.
  Wydane: (2003-01-01)